DrugPatentWatch Database Preview
GVOKE HYPOPEN Drug Profile
» See Plans and Pricing
When do Gvoke Hypopen patents expire, and when can generic versions of Gvoke Hypopen launch?
Gvoke Hypopen is a drug marketed by Xeris and is included in one NDA. There is one patent protecting this drug.
This drug has sixteen patent family members in thirteen countries.
The generic ingredient in GVOKE HYPOPEN is glucagon. There are twelve drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the glucagon profile page.
US ANDA Litigation and Generic Entry Outlook for Gvoke Hypopen
A generic version of GVOKE HYPOPEN was approved as glucagon by LILLY on September 11th, 1998.
Summary for GVOKE HYPOPEN
| International Patents: | 16 |
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for GVOKE HYPOPEN |
| DailyMed Link: | GVOKE HYPOPEN at DailyMed |
US Patents and Regulatory Information for GVOKE HYPOPEN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Xeris | GVOKE HYPOPEN | glucagon | SOLUTION;SUBCUTANEOUS | 212097-003 | Sep 10, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Xeris | GVOKE HYPOPEN | glucagon | SOLUTION;SUBCUTANEOUS | 212097-004 | Sep 10, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Xeris | GVOKE HYPOPEN | glucagon | SOLUTION;SUBCUTANEOUS | 212097-003 | Sep 10, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Xeris | GVOKE HYPOPEN | glucagon | SOLUTION;SUBCUTANEOUS | 212097-004 | Sep 10, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for GVOKE HYPOPEN
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Africa | 201801912 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2017053922 | Start Trial |
| Israel | 258298 | Start Trial |
| European Patent Office | 3307295 | Start Trial |
| Canada | 2999404 | Start Trial |
| Hong Kong | 1250644 | Start Trial |
| China | 108135980 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
